Blog
- The Importance of Mass Tort Actions in Cases Like Quartz Countertop Silicosis
Dec 5, 2024
In recent years, quartz countertops have gained immense popularity for their sleek appearance and durability. However, a darker reality has emerged: the production of these engineered stones has led to deadly cases of silicosis among workers exposed to silica dust. The tragic story of Marek Marzec, a 48-year-old father of three who was given weeks to live due to silicosis, has brought this crisis to national attention. His harrowing experience was featured in PEOPLE magazine, highlighting...Read More - Kila Baldwin Says Out Loud What the Medical Malpractice Defense Bar Doesn’t Want to Admit
Dec 4, 2024
The Philadelphia Court of Common Pleas is signaling a shift in how medical malpractice cases are managed, with aggressive trial scheduling becoming the new norm. This approach, aimed at keeping up with a surge in filings, has created a stark divide in how the legal community is reacting—particularly between the plaintiffs and defense bars. Anapol Weiss shareholder Kila Baldwin recently commented on the situation in The Legal Intelligencer, pointing out what she sees as a fundamental...Read More - Guide to Understanding Wrongful Death and Survival Actions in Pennsylvania
Dec 4, 2024
Losing a loved one can be daunting, particularly when he or she dies due to the negligence of another. If you find yourself in this situation, you may be able to seek legal recourse. In Pennsylvania, two causes of action may be available under these circumstances: (1) wrongful death, and (2) survival actions. Wrongful Death Claims and Distribution of Proceeds A loved one’s surviving spouse, children, or parent may recover damages when the death of an individual was...Read More - Guide to Roblox Lawsuits and How to Sign Up
Dec 4, 2024
Roblox, one of the world’s largest and fastest-growing gaming platforms, has been accused of failing to protect its young users from harmful and predatory content. In 2023, Anapol Weiss attorneys Alexandra Walsh and Pat Huyett filed a class action lawsuit against Roblox on behalf of families who were misled by Roblox’s deceptive advertising and suffered financial harm as a result. Then in the summer of 2024, Hindenburg Research issued a damning report against Roblox, concluding that Roblox...Read More - CHOP's Oversight Failure: A System That Risked Lives
Dec 3, 2024
In the world of medicine, groundbreaking procedures offer hope for those with dire conditions. Yet, such innovation must always be accompanied by rigorous oversight and transparency to the patients about the risks, both known and unknown. The Philadelphia Inquirer's investigation of the Children’s Hospital of Philadelphia (CHOP) and its pioneering lymphatic procedure for plastic bronchitis tragically reveals what happens when these safeguards fail. What is Plastic Bronchitis? Plastic bronchitis is a rare and potentially life threatening...Read More - From a Judicial Clerkship to Taking on Big Pharma
Dec 2, 2024
Tyler Davis recently joined Anapol Weiss as an associate, working on the transvaginal mesh litigation. This litigation is focused on having pharmaceutical giants like Johnson & Johnson, Boston Scientific, and Coloplast take responsibility for the mesh implants they made to treat stress urinary incontinence and pelvic organ prolapse in women. The mesh products they sold were not needed – there are alternative surgeries and non-surgical treatments for these conditions, and the mesh products cause life-altering...Read More - Hindenburg Report on Roblox: “X-Rated Pedophile Hellscape”
Dec 2, 2024
Key Findings and Implications The recent Hindenburg Research report on Roblox Corporation used these words to describe what it found during its in-game research: “an X-rated pedophile hellscape, exposing children to grooming, pornography, violent content and extremely abusive speech.” The report noted as well that The National Center on Sexual Exploitation in 2024 labeled Roblox “a tool for sexual predators, a threat for childrens’ safety”. At Anapol Weiss, we are dedicated to holding corporations accountable when their...Read More - Depo-Provera Lawsuits, Meningioma Tumors, and How to File
Dec 2, 2024
Meningiomas are the most common type of brain tumor, accounting for approximately 30% of all brain tumors, according to the Mayo Clinic. Although most meningiomas are benign, their location and growth can cause significant challenges, particularly when they are deemed inoperable. Recent studies have raised concerns about the potential link between prolonged use of Depo-Provera, a popular injectable contraceptive, and an increased risk of developing meningiomas. This revelation has led to lawsuits alleging that users were...Read More - Progesterone Contraceptive Depo-Provera Linked to Meningioma Brain Tumors
Nov 27, 2024
Emerging research highlights significant risks associated with prolonged use of certain hormonal contraceptives. Studies now reveal troubling links between progesterone-based contraceptives, such as Depo-Provera, and an increased risk of intracranial meningiomas—serious brain tumors that can cause complications, including vision loss. A recent October 2024 study from the University of Cincinnati, along with pivotal research published earlier in Cancers and The BMJ, underscores the need for greater awareness and accountability regarding long-term injectable contraceptive use. October 2024 Study:...Read More - September Study Links Prolonged Depo-Provera Use to Increased Risk of Brain Tumors
Nov 24, 2024
In September 2024, a significant study published in the journal Cancers revealed a troubling link between the prolonged use of Depo-Provera, an injectable contraceptive containing depot medroxyprogesterone acetate (dMPA), and an increased risk of developing cerebral meningiomas. The large-scale case-control study analyzed over 117,000 meningioma cases and more than one million matched controls using data spanning 2006–2022. It found that “injection exposure” to medroxyprogesterone acetate (Depo-Provera) was associated with a 53% increase in the risk...Read More